IFLR1000

Integrated Diagnostics Holdings LSE IPO

15/5/2015
IPO
Select tab

$ 668 million

Completed

15/5/2015

Overview:

  • Integrated Diagnostics Holdings (IDH) has undertaken an IPO on the LSE.
  • The MENA diagnostics provider has announced a listing price of $4.45 a share valuing the overall company at $668 million.
  • The company which operates in Egypt, Jordan and Sudan, announced its intention to list in January 2015.
  • IDH offers pathology and molecular diagnostics, genetics testing and basic radiology to patients and laboratories.
  • Citigroup, Deutsche Bank and EFG Hermes acted as underwriters.

Sam Duke - Editor

Jurisdictions:

Egypt
United Kingdom
Channel Islands: Jersey

Deal type:

IPO

Practice area:

Capital markets : Equity

Industry sector:

Technology and telecommunications

Firms:
Freshfields Bruckhaus Deringer

Party: Integrated Diagnostics Holdings (Issuer)

Lawyer: Christopher Mort

Matouk Bassiouny

Party: Integrated Diagnostics Holding (Issuer)

Ogier

Party: Integrated Diagnostics Holding (Issuer)

Lawyer: Richard Daggett

Shearman & Sterling

Party: Citigroup (Underwriter)

Party: Deutsche Bank AG Na ON (Underwriter)

Party: EFG Hermes (Underwriter)

Lawyers: Barnabas (Barney) Reynolds, James Duncan, Thomas Donegan

Zulficar & Partners

Party: Citigroup (Underwriter)

Party: Deutsche Bank AG Na ON (Underwriter)

Party: EFG Hermes (Underwriter)

Related deals